Colleen Alabiso News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Ipsen to Acquire Albireo Accelerating Growth in Rare Disease With Treatments for Several Pediatric Liver Diseases

Transaction focused on Bylvay (odevixibat), the first-approved treatment in progressive familial intrahepatic cholestasis in U.S. and E.U., with potential in other rare diseases Acquisition

France generalUnited statesUnited kingdomVastra gotalands lanMecklenburg vorpommernSrivastavaaj clinAnna gibbinsHans vitzthumBakera clinDavid loewGunaydinm hepatIpsen euronextFeldmanag neoreviewsHopkins pj pediatrAldriandj clinIoana piscociu

Albireo (ALBO) Acquired by Ipsen for $42/sh plus $10 CVR

Albireo (ALBO) Acquired by Ipsen for $42/sh plus $10 CVR
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

France generalUnited statesUnited kingdomVastra gotalands lanMecklenburg vorpommernSrivastavaaj clinAnna gibbinsHans vitzthumBakera clinDavid loewGunaydinm hepatFeldmanag neoreviewsHopkins pj pediatrAldriandj clinIoana piscociuLykavierisp heptology

Albireo Pharma : Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases

Full Text View - ClinicalTrials.gov Hopkins P J Pediatr. 2017;187:253-257. doi: 10.1016/j.jpeds.2017.05.006. Epub 2017 Jun 1. . | January 9, 2023

France generalUnited statesUnited kingdomVastra gotalands lanMecklenburg vorpommernColleen alabisoAnna gibbinsHans vitzthumDavid loewRon cooperAmy wolfIpsen euronextIoana piscociuOrrick herrington sutcliffeLifesci advisorsGoldman sachs

Ipsen to acquire Albireo accelerating growth in rare disease with treatments for several pediatric liver diseases

Ipsen and Albireo announced that they have entered into a definitive merger agreement under which Ipsen will acquire Albireo, a leading innovator in bile-acid modulators to treat pediatric and adult cholestatic liver diseases.

France generalUnited statesUnited kingdomVastra gotalands lanMecklenburg vorpommernColleen alabisoAnna gibbinsHans vitzthumDavid loewRon cooperAmy wolfIpsen euronextIoana piscociuOrrick herrington sutcliffeLifesci advisorsGoldman sachs

Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Albireo Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesVastra gotalands lanColleen alabisoAlbireoalbireo pharmaLance buckleyHans vitzthumPauld streckAlbireo pharma incLifesci advisorsChief medical officerNasdaq listing ruleEquity incentiveOpen label extensionAlbireo pharma